國立虎尾科技大學 |

Small molecule therapeutics for schizophrenia

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Small molecule therapeutics for schizophrenia/ edited by Sylvain Celanire, Sonia Poli.
other author:	Celanire, Sylvain.
Published:	Cham :Springer International Publishing : : 2015.,
Description:	vii, 323 p. :ill. (some col.), digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Schizophrenia - Chemotherapy. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-11502-3
ISBN:	9783319115023 (electronic bk.)

Small molecule therapeutics for schizophrenia
Small molecule therapeutics for schizophrenia[electronic resource] /edited by Sylvain Celanire, Sonia Poli. - Cham :Springer International Publishing :2015. - vii, 323 p. :ill. (some col.), digital ;24 cm. - Topics in medicinal chemistry,131862-2461 ;. - Topics in medicinal chemistry ;8..

Antipsychotics and the Dopamine Serotonin Connection -- GLYT1 Inhibitors: From Hits to Clinical Candidates -- Metabotropic Glutamate Receptor 2 Activators -- Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders -- Muscarinic Acetylcholine Receptor Activators -- Nicotinic Acetylcholine Receptor Modulators -- The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.

The topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drug ability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine.

ISBN: 9783319115023 (electronic bk.)

Standard No.: 10.1007/978-3-319-11502-3doiSubjects--Topical Terms:

583753
Schizophrenia
--Chemotherapy.

LC Class. No.: RC514

Dewey Class. No.: 616.89806

Small molecule therapeutics for schizophrenia
LDR:02593nam a2200325 a 4500 001 834588
003 DE-He213
005 20150611092205.0
006 m d
007 cr nn 008maaau
008 160421s2015 gw s 0 eng d
020 $a 9783319115023 (electronic bk.)
020 $a 9783319115016 (paper)
024 7 $a 10.1007/978-3-319-11502-3 $2 doi
035 $a 978-3-319-11502-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC514
072 7 $a PSB $2 bicssc
072 7 $a SCI013020 $2 bisacsh
082 0 4 $a 616.89806 $2 23
090 $a RC514 $b .S635 2015
245 0 0 $a Small molecule therapeutics for schizophrenia $h [electronic resource] / $c edited by Sylvain Celanire, Sonia Poli.
260 $a Cham : $c 2015. $b Springer International Publishing : $b Imprint: Springer,
300 $a vii, 323 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Topics in medicinal chemistry, $x 1862-2461 ; $v 13
505 0 $a Antipsychotics and the Dopamine Serotonin Connection -- GLYT1 Inhibitors: From Hits to Clinical Candidates -- Metabotropic Glutamate Receptor 2 Activators -- Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders -- Muscarinic Acetylcholine Receptor Activators -- Nicotinic Acetylcholine Receptor Modulators -- The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.
520 $a The topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drug ability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine.
650 0 $a Schizophrenia $x Chemotherapy. $3 583753
650 1 4 $a Chemistry. $3 593913
650 2 4 $a Medicinal Chemistry. $3 668872
650 2 4 $a Psychopharmacology. $3 644799
650 2 4 $a Neurosciences. $3 593561
700 1 $a Celanire, Sylvain. $3 1063187
700 1 $a Poli, Sonia. $3 1063188
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Topics in medicinal chemistry ; $v 8. $3 884548
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-11502-3
950 $a Chemistry and Materials Science (Springer-11644)